Mon, Nov 16, 2026
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Biotech VC firm Flagship Pioneering raises $1.1bn for latest fund amid pandemic

Friday, April 03, 2020

Laxman Pai, Opalesque Asia:

Massachusetts-based venture capital firm Flagship Pioneering managed to raise $1.1 billion for its seventh "origination fund" to support biotech startups, despite the economy is being disrupted by the COVID-19 pandemic.

The VC firm specializing in company creation started biotech concern Moderna, company that has produced an experimental vaccine for the novel coronavirus.

Flagship develops and operates startups that leverage biotechnology innovation to provide goods and services that improve human health and promote sustainable industries. Since its launch in 2000, the firm has fostered more than 100 scientific ventures, resulting in over $34 billion in aggregate value.

Since it was founded, Flagship has raised $4.4 billion, with more than $1.9 billion used to start and expand companies.

The firm's seventh origination fund will support the creation of Human Health and Sustainability companies originated and operating within its Flagship Labs unit.

This new capital pool will operate alongside separate Flagship funds totaling $1.08 billion raised in 2019 to support the financial needs of Flagship-originated companies after they spin-out from Flagship Labs and enter their growth stage.

"We're honored to have the strong support of our existing Limited Partners, as well as the interest from a select group of new Limited Partners, to support Flagship's unique form of company origination during this time of unprecedented economic ......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: DACH institutions push alternatives to 32.3% of portfolios as hedge funds make a comeback[more]

    Matthias Knab, Opalesque for New Managers: Institutional investors in Germany, Austria and Switzerland now hold almost a third of their portfolios in alternative investments, and they are more confident than ever in

  2. KRX chief courts CalPERS for bigger bet on Korea[more]

    Korea Exchange Chairman and CEO Jeong Eun-bo held talks with California Public Employees' Retirement System, or CalPERS, to promote greater investment in South Korea's capital markets, the bourse operator announced Wednesday. Jeong met with CalPERS Chief Investment Officer Stephen Gilmore.

  3. 755 Unicorns, $8 Trillion: Fifth Era maps the autonomous digital economy[more]

    Matthias Knab, Opalesque for New Managers: Fifth Era Partners, a specialized asset manager focused on the convergence of Internet, AI/Agentic and Blockchain technologies, has released the findings of its 13th Bia

  4. Opalesque Exclusive: "Enough beta plays" - how Fasanara builds an alpha-only multi-strategy platform[more]

    Matthias Knab, Opalesque for New Managers: Most multi-strategy funds promise diversification. Fewer can explain why their return streams should stay independent when markets turn. In an Opalesque SkillsLab investor

  5. Opalesque Exclusive: Governance, Scale, and Boutique Resilience in a Consolidating Hedge Fund Industry[more]

    Matthias Knab, Opalesque for New Managers: The hedge fund industry has undergone significant consolidation in recent years, with capital increasingly concentrated among large multi-strategy platforms. Yet boutique m